Market
Aclaris Therapeutics Inc [ACRS] Revenue clocked in at $21.43 million, up 0.95% YTD: What’s Next?
Aclaris Therapeutics Inc [NASDAQ: ACRS] price plunged by -7.02 percent to reach at -$0.08. The company report on January 16, 2024 at 7:00 AM that Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review. – Douglas Manion, M.D. to step down as Chief Executive Officer,
